autologous mesenchymal stem cell therapy (MedCell)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameautologous mesenchymal stem cell therapy (MedCell)
Drug Alias NameMS-ten
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionMusculoskeletal system modulators
TargetsUpdating
Therapy Area/IndicationsConnective Tissue Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedCell Bioscience Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedCell Bioscience Ltd
Active IndicationsN/A
Inactive IndicationsConnective Tissue Diseases

Other Information

ATC CodeN/A
Related LinksN/A